Today, it is not enough to develop an exceptional drug. Pharma companies must also offer exceptional support products and services alongside their brand.

These are not (and should not be) static offerings. Rather, they must be flexible, efficient and have longevity to accommodate the increasingly dynamic world of pharma – especially in therapy areas inundated with new treatments, updated indications and new avenues for patients to take part in their own care.

Download the full article by Matthew Nulty – Associate, Incite Marketing Planning and Lizzie Eckardt – Principal, Incite Marketing Planning

Disclaimer: The views and opinions expressed in this feature are those of the author and may not reflect the official policy or position of the BHBIA. The BHBIA have not verified any of the information quoted and do not accept any responsibility for its accuracy, or otherwise.